Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Champions Call for Lower Prescription Drug Costs, and More in Meeting with Congressional Legislators

From the College  |  Issue: October 2017  |  October 16, 2017

ACR advocates recently returned to Capitol Hill to meet with members of Congress as part of the Advocates for Arthritis fly-in conference on Sept. 26. This annual event brings together rheumatology professionals to advocate on behalf of the rheumatology community. Core issues on which the advocates focused this year include lowering the out-of-pocket cost of prescription drugs, the repeal of arbitrary Medicare therapy caps and to shed light on the role of pharmacy benefit managers in drug pricing.

Help Strengthen the ACR’s Voice in Washington, D.C.

It will take the voice of all rheumatology professionals and patients to get Congress to act. Write, call or email your legislators. As a constituent, your members of Congress are elected to represent you. Ask them to support these priorities:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Reduce Patients’ Out-of-Pocket Expenses

  • House: Cosponsor H.R. 2999, the Patients’ Access to Treatments Act, to limit patients’ cost-sharing requirements for specialty tier drugs and increase access to lifesaving biologics.
  • Senate: Introduce the Patients’ Access to Treatment Act (PATA) in the Senate; Request a Senate hearing on the use of specialty-tier drug pricing.

Repeal Medicare Therapy Caps

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • House: Cosponsor H.R. 807, the Medicare Access to Rehabilitation Services Act, legislation that would repeal the cap on outpatient rehabilitation services.
  • Senate: Cosponsor S. 253, the Medicare Access to Rehabilitation Services Act.

Expose Pharmacy Benefit Managers’ Role in Prescription Drug Pricing

  • PBMs can drive up drug costs by creating market pressure for higher list prices (the higher the list price, the higher the rebate).
  • PBMs use their position to negotiate contracts with manufacturers, insurers and pharmacies that maximize their profits, often at the expense of patients.
  • PBMs use spread pricing in which they charge an insurer a different amount for given drugs than what it reimburses the pharmacy for dispensing the drugs. This may be kept as extra profit by the PBM.
  • PBMs use drug-switching practices, which increase profits by steering patients toward expensive medications whose manufacturers pay rebates to PBMs for promoting a particular drug.

Be an Effective Advocate When Members of Congress Are at Home

  • Invite your legislators to your office. This is a great opportunity to educate members of Congress on the importance of the rheumatology subspecialty and the effect that arthritis and rheumatic conditions have on quality of life.
  • Meet with your legislators in their district office. An in-person meeting is an effective way to convey your message and allows you to build relationships with your legislators.
  • Volunteer for a campaign. Volunteering is a great way to get involved in the political process. Support the candidate who will best represent the rheumatology community.

We must stay united to effect change. Contact your elected officials and make your voice heard. To find your legislators’ contact information or for more information on ACR advocacy activities, contact [email protected], or visit www.rheumatology.org/advocacy.

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:AdvocacyAdvocates for ArthritisCapitol HillCongressHealthcarelawmakerslegislatorsMedicaidMedicareprescription drug costsreformRheumatic Diseaserheumatology

Related Articles

    Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing

    December 20, 2017

    SAN DIEGO—The 2017 ACR/ARHP Annual Meeting, Nov. 3–8, presented opportunities to highlight its 2017 legislative advocacy victories, some of which were resolved just weeks before the conference began, as well as issues that are still outstanding. In the session, Legislative & Regulatory Update 2017, Angus Worthing, MD, chair of the ACR’s Government Advocacy Committee and…

    Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting

    January 19, 2018

    SAN DIEGO—Pharmacy benefit managers (PBMs) and their impact on drug prices and access to high-cost medications by the patients rheumatologists treat was a major theme at the 2017 ACR/ARHP Annual Meeting Nov. 3–8. In one session, industry experts tried to clarify the role for prior authorizations and drug formulary policies and explored ways to constructively…

    Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

    August 8, 2022

    As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

    Help the ACR Bring Its Message to the Hill

    September 6, 2017

    The ACR will be back on Capitol Hill Sept. 26 to advocate for lower out-of-pocket costs of prescription drugs and the repeal of arbitrary Medicare therapy caps, as well as to shed light on the role of pharmacy benefit managers (PBMs) in drug pricing. But it will take the voice of all rheumatology professionals and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences